Viewing Study NCT01048034


Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2026-02-04 @ 5:27 AM
Study NCT ID: NCT01048034
Status: COMPLETED
Last Update Posted: 2013-10-29
First Post: 2010-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)
Sponsor: Nordic MDS Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module